Literature DB >> 24224133

Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?

Rory J Kelleher1, Roy L Soiza.   

Abstract

The etiology of Alzheimer's disease (AD) remains unclear. The emerging view is that cerebrovascular dysfunction is a feature not only of cerebrovascular diseases, such as stroke, but also of neurodegenerative conditions, such as AD. In AD, there is impaired structure and function of cerebral blood vessels and cells in the neurovascular unit. These effects are mediated by vascular oxidative stress. Injury to the neurovascular unit alters cerebral blood flow regulation, depletes vascular reserves, disrupts the blood-brain barrier and reduces the brain's repair capacity. Such injury can exacerbate the cognitive dysfunction exerted by incident ischemia and coexisting neurodegeneration. This article summarises data regarding cardiovascular risk factors, vascular abnormalities and brain endothelial damage in AD. In view of accumulating evidence of vascular pathology in AD, we also review the literature (MEDLINE, EMBASE) for clinical evidence of impaired endothelial function in AD. A total of 15 articles investigating endothelial dysfunction in AD were identified. 10 of these articles showed impaired endothelial function in AD patients. The current literature suggests endothelial dysfunction may be involved in the pathogenesis of AD. This aspect of AD pathology is particularly interesting in view of its potential for therapeutic intervention. Future research on endothelial function in AD should concentrate on population-based analysis and combine multiple methods to evaluate endothelial function.

Entities:  

Keywords:  Alzheimer’s; dementia; endothelial dysfunction; endothelium; etiology; neurodegeneration; pathology; vascular disease

Year:  2013        PMID: 24224133      PMCID: PMC3819581     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  267 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Limitations of non-invasive endothelial function assessment by brachial artery flow-mediated dilatation.

Authors:  Tomás Sejda; Jan Pit'ha; Eva Svandová; Rudolf Poledne
Journal:  Clin Physiol Funct Imaging       Date:  2005-01       Impact factor: 2.273

3.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

4.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

5.  Safety evaluation of routine intracoronary acetylcholine infusion in patients undergoing a first diagnostic coronary angiogram.

Authors:  R A Tio; S H J Monnink; G Amoroso; G A J Jessurun; N Veeger; C Volkers; R Hautvast; E S Tan; W H van Gilst; A J van Boven
Journal:  J Investig Med       Date:  2002-03       Impact factor: 2.895

6.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

7.  Impaired peripheral endothelial microvascular responsiveness in Alzheimer's disease.

Authors:  Z Khalil; D LoGiudice; B Khodr; P Maruff; C Masters
Journal:  J Alzheimers Dis       Date:  2007-03       Impact factor: 4.472

8.  Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain.

Authors:  K Jendroska; W Poewe; S E Daniel; J Pluess; H Iwerssen-Schmidt; J Paulsen; S Barthel; L Schelosky; J Cervós-Navarro; S J DeArmond
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury.

Authors:  S M Gentleman; M J Nash; C J Sweeting; D I Graham; G W Roberts
Journal:  Neurosci Lett       Date:  1993-10-01       Impact factor: 3.046

10.  Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease.

Authors:  Oda-Christina Suter; Thanomphone Sunthorn; Rudolf Kraftsik; Joel Straubel; Pushpa Darekar; Kamel Khalili; Judith Miklossy
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

View more
  83 in total

Review 1.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Endothelial Activation Is Associated With Cognitive Performance in Patients With Hypertension.

Authors:  Renske Uiterwijk; Marjolein Huijts; Julie Staals; Rob P W Rouhl; Peter W De Leeuw; Abraham A Kroon; Robert J Van Oostenbrugge
Journal:  Am J Hypertens       Date:  2015-08-12       Impact factor: 2.689

Review 3.  Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration.

Authors:  Brandon P Lucke-Wold; Ryan C Turner; Aric F Logsdon; James W Simpkins; Daniel L Alkon; Kelly E Smith; Yi-Wen Chen; Zhenjun Tan; Jason D Huber; Charles L Rosen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Compartmental and Data-Based Modeling of Cerebral Hemodynamics: Nonlinear Analysis.

Authors:  Brandon Christian Henley; Dae C Shin; Rong Zhang; Vasilis Z Marmarelis
Journal:  IEEE Trans Biomed Eng       Date:  2016-07-09       Impact factor: 4.538

Review 5.  Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.

Authors:  Milos D Ikonomovic; Zhiping Mi; Eric E Abrahamson
Journal:  Ageing Res Rev       Date:  2016-11-06       Impact factor: 10.895

6.  Risk and protective factors for cognitive impairment in persons aged 85 years and older.

Authors:  Rosebud O Roberts; Ruth H Cha; Michelle M Mielke; Yonas E Geda; Bradley F Boeve; Mary M Machulda; David S Knopman; Ronald C Petersen
Journal:  Neurology       Date:  2015-04-08       Impact factor: 9.910

Review 7.  TREK-king the blood-brain-barrier.

Authors:  Stefan Bittner; Tobias Ruck; Juncal Fernández-Orth; Sven G Meuth
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-21       Impact factor: 4.147

Review 8.  P2Y receptors in Alzheimer's disease.

Authors:  Laurie Erb; Chen Cao; Deepa Ajit; Gary A Weisman
Journal:  Biol Cell       Date:  2014-10-13       Impact factor: 4.458

9.  Regulating effect of CBF on memory in cognitively normal older adults with different ApoE genotype: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Junyang Wang; Guoping Peng; Ping Liu; Xufei Tan; Benyan Luo
Journal:  Cogn Neurodyn       Date:  2019-05-11       Impact factor: 5.082

Review 10.  Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.